Now showing items 1-4 of 4
High-dose cisplatin in advanced head and neck cancer
(Springer-Verlag, 1987-04)
In 22 patients with advanced squamous cell carcinoma of the head and neck we evaluated the efficacy and toxicity of 200 mg/m 2 cisplatin administered in 3% NaCl with vigorous hydration. Six patients had previously untreated ...
Phase II Trial of Docetaxel Chemotherapy in Patients with Incurable Adenocarcinoma of the Esophagus
(Kluwer Academic Publishers; Springer Science+Business Media, 2002-02)
Background : Chemotherapy remains theprimary mode of treatment for metastaticcarcinoma of the esophagus. The efficacyof various chemotherapeutic regimens hasbeen studied predominantly in patients withsquamous cell carcinoma ...
Multicenter phase II trial of brequinar sodium in patients with advanced squamous-cell carcinoma of the head and neck
(Springer-Verlag, 1992-03)
A total of 19 patients with advanced squamous-cell carcinoma of the head and neck who had not previously been exposed to chemotherapy were treated with brequinar sodium as first-line chemotherapy. Brequinar was given ...
Gemcitabine and Cisplatin for Patients with Metastatic or Recurrent Esophageal Carcinoma: A Southwest Oncology Group Study
(Kluwer Academic Publishers; Springer Science+Business Media, 2004-01)
Purpose : Experimental data, both in vivo and in vitro , suggest that the combination of gemcitabine and cisplatin acts synergistically. Within the Southwest Oncology Group, we designed a Phase II trial to test this ...